Adam Livingston, Clinical Pharmacist, Medical Cannabis Consultant, & Deprescribing Program CoordinatorWithin this landscape, over forty years ago, stood Kent McLeod, a renowned pharmacist who embarked on an ambitious journey by founding NutriChem. His vision was to enhance patient therapeutics by customizing medications. Recognizing the gaps in traditional medical treatments, McLeod explored alternative natural remedies, not readily available in the commercial markets.
This move began his remarkable journey in the compounding pharmacy sector, introducing a paradigm shift that has since been reshaping the conventional practices of polypharmacy.
Today, NutriChem, an integrative pharmacy and clinic led by a dynamic young pharmacy manager, still emphasizes personalized patient care. “Our vision revolves around identifying the best or optimal treatment for each patient when commercially available options fall short,” says Adam Livingston, clinical pharmacist, medical cannabis consultant, and deprescribing program coordinator at NutriChem.
Central to NutriChem’s approach is a patient-focused therapeutic model, leveraging compounding to formulate precise chemical solutions. Its advanced facilities, capable of handling sterile and non-sterile hazardous compounds, set an industry benchmark. The range of services extends to IV therapy, body chemistry balancing, custom vitamin compounding, and naturopathic medicine, ensuring a holistic health approach.
Despite these significant advancements, obtaining insurance coverage for compounded medications persists. NutriChem fiercely advocates patient rights, persistently engaging in discussions and battles with insurance companies to secure coverage for essential medicines. This tireless effort illuminates a critical gap in patient access, underscoring the pressing need for continued advocacy.
Integrating naturopathic practices, NutriChem blends Western and Eastern medical models to customize bioidentical hormone dosages, offering personalized formulations in creams, capsules, and injections for both men and women. It steers clear of standardized, mass-produced remedies, acknowledging the substantial variability in optimal hormone levels among individuals.
NutriChem extends its expertise to fertility treatments, collaborating with local fertility clinics as well as catering to hormone-related needs in gender transition therapies. A significant focus lies in developing personalized pain creams as alternatives to opioids, contributing to harm reduction while offering a safer transdermal option.
The therapeutic gap in commercially available lower doses for gradual discontinuation of psychotropic medications forces individuals to reduce their medication doses too rapidly. This often leads to withdrawal symptoms, particularly with antidepressants or benzodiazepine sleeping pills.
Our vision revolves around identifying the best or optimal treatment for each individual patient when commercially available options fall short
For instance, the team compounds specialized doses that enable a gradual reduction, typically by around 10 percent every two weeks over an extended period spanning weeks or even months. This helps minimize withdrawal symptoms, ensuring a safer transition for patients.
Recently, NutriChem celebrated a remarkable milestone as a patient successfully ceased diazepam dosage after over a decade, witnessing substantial improvements in alertness, cognition, and reduced fall risks. This success story emphasizes the pivotal role of precise medication management and tailored interventions in enhancing overall well-being.
Guided by patient wellness as a core principle, its steadfast commitment to innovation, patient advocacy, and holistic care solidifies its position as the pinnacle of compounding pharmacy to offer the best-suited treatment.
